Outlook Therapeutics Inc (NASDAQ:OTLK)

2.40
Delayed Data
As of Sep 17
 0.00 / 0.00%
Today’s Change
0.63
Today|||52-Week Range
4.26
+84.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues771.9K771.9K1.1M641.1K
 
 
 
 
 
Depreciation And Amortization822.1K824.4K823.1K816.5K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses7.2M8.2M10.5M7.5M
 
 
 
 
 
Research And Development5.8M7.1M8.4M6.5M
 
 
 
 
 
Total Operating Expenses8.0M9.0M11.3M8.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.2M-8.2M-10.3M-7.7M
 
 
 
 
 
Extraordinary Credit0.00821.6K1.6M0.00
 
 
 
Extraordinary Charge-64.7K-4.2M-3.6K-1.5M
 
 
 
 
 
Interest Expense On Debt1.1M1.1M1.1M1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.4M-12.7M-9.7M-10.2M
 
 
 
 
 
Income Taxes0.00-497.5K0.000.00
 
 
Preferred Dividend-652.6K-163.8K-150.5K-983.8K
 
 
 
 
 
Net Income-8.4M-12.5M-9.7M-10.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.3M9.0M9.8M11.5M
 
 
 
 
 
Shares To Calculate EPS Diluted4.3M9.0M9.8M11.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.08-$1.40-$1.04-$0.98
 
 
 
 
 
EPS Diluted-$2.08-$1.40-$1.00-$0.98